Sight Sciences announced the commercial availability of the Omni Ultra Surgical System, an expansion of its ab interno canaloplasty platform. The new technology will be featured at the American Academy of Ophthalmology (AAO) annual meeting held on October 9-12 in New Orleans, the company said in a press release.
According to Sight Sciences, Omni Ultra enables single pass canaloplasty followed by trabeculotomy while also featuring TruSync Plus technology and enhanced catheter visualization. Omni Ultra is designed to reduce intraocular pressure (IOP) by addressing all 3 known areas of resistance within the conventional aqueous outflow pathway: the trabecular meshwork, Schlemm’s canal, and the collector channels. The technology can be used in a standalone procedure or in combination with cataract surgery in adult patients with primary open-angle glaucoma.
In addition, the Omni Ultra features comprehensive implant-free intervention that specifically addresses all 3 known areas of outflow resistance through a single, clear corneal microincision without leaving an implant behind. In addition, it also features single pass canaloplasty that allows the surgeon to accesse the entire circumference of Schlemm’s canal with a single pass for canaloplasty followed by trabeculotomy. TruSync Plus technology provides automatic and predictable viscodilation of Schlemm’s canal upon both advancement and retraction of the microcatheter throughout the canaloplasty procedure. Omni Ultra also features expanded treatment versatility for the customized treatment across varying disease severities and surgical settings while supporting enhanced catheter visualization to help surgeons assess and tailor treatment delivery, the company said in the press release.
Beyond Interventional Glaucoma and within its Interventional Dry Eye business, Sight Sciences said the company will also preview the new Clearance Assistant Plus at AAO, a dual-action tool designed for both meibomian gland expression and eyelid debridement for use with the TearCare System. GP